Royal Philips said its emergency care and resuscitation (ECR) business has been operating under a consent decree with the FDA since November 2017. Under the terms of the consent decree, Philips was required to suspend manufacture and distribution of its defibrillators from specific Philips facilities...
FDA Enters Consent Decree Against Philips Respironics 10 Apr 2024 // PR NEWSWIRE Philips Respironics Agrees on Consent Decree with US Government 10 Apr 2024 // GLOBENEWSWIRE Philips Foundation And March of Dimes Partner to Improve Prenatal Care Access ...
Philips still has to reach a settlement with the U.S. Food and Drug Administration (FDA) and is also facing lawsuits from individual patients over health problems they claim were caused by the devices. "The more significant medical litigation risk and the consent decree impact r...
2022 has been a very difficult year for Philips and our stakeholders, and we are taking firm actions to improve our execution and step up performance with urgency.
December 23, 2024 · 207 min read · BioSpace Editorial Staff Drug shortages FDA Confirms Lilly’s GLP-1s Are Not in Shortage, Gives Compounders Grace Period December 19, 2024 · 3 min read · Tristan Manalac Layoffs Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs...
Create Portfolio Portfolio Health Check Alert Preferences Subscriptions Premium & Pro About Premium Group Subscriptions Alpha Picks About Alpha Picks FREE Newsletters Investing Groups Learn About Investing Groups Most Popular Free Trials Top Rated Dividend Investing Value Investing Options T...
In addition to consent decree talks with the DOJ and FDA, Philips also faces lawsuits. The recall involves potential health risks caused by polyester-based polyurethane (PE-PUR) sound abatement foam breaking down. Foam particles could enter a device’s air pathway. The particles could cause a ...
Philips is restricted from selling many sleep and respiratory products in the U.S., per the terms of aconsent decreeit struck with the Department of Justice and FDA earlier this year. The companypreviously recalled the BiPAP machinesin 2022 because they contained contaminated plastic and in 2021...
The companyfirst announced the problemin mid-2021, but efforts to repair or replace the machines have dragged on for years, frustrating patients in the U.S. and other countries. The Dutch company said it has agreed to a consent decree with the Food and Drug Administration and the Department...
The Dutch manufacturing giant said it has agreed to a consent decree with the Food and Drug Administration and the Department of Justice. The deal has not yet been finalized and will have to be approved by a U.S. judge. Philips executives disclosed the tentative agreement during a quarterly ...